Concepedia

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial

Daniel E. Spratt, Vinnie Y.T. Liu, Jeff M. Michalski, Elai Davicioni, Alejandro Berlín, Jeffry Simko, Jason A. Efstathiou, Phuoc T. Tran, Howard M. Sandler, William A. Hall,

International Journal of Radiation Oncology*Biology*Physics · 2023 · 34 citations · 14 references

DOIFull text

Open access

Concepts

References

14

Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers

Richard Simon, Seungmok Paik, Daniel F. Hayes · JNCI Journal of the National Cancer Institute · 2009 · 1K citations · Full text

, , +17

Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer

Christopher U. Jones, Daniel Hunt, D.G. McGowan et al. · New England Journal of Medicine · 2011 · 701 citations · Full text

, , +14

Effect of Standard vs Dose-Escalated Radiation Therapy for Patients With Intermediate-Risk Prostate Cancer

Jeff M. Michalski, Jennifer Moughan, James A. Purdy et al. · JAMA Oncology · 2018 · 358 citations · Full text

, , +17

Tissue-based Genomics Augments Post-prostatectomy Risk Stratification in a Natural History Cohort of Intermediate- and High-Risk Men

Ashley E. Ross, Michael H. Johnson, Kasra Yousefi et al. · European Urology · 2015 · 247 citations

, , +14

Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer

Daniel E. Spratt, Jingbin Zhang, María Santiago‐Jiménez et al. · Journal of Clinical Oncology · 2017 · 213 citations

, , +15